Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Diabetes|January 2, 2015
Reactivated CD4+Tm cells of T1D patients and siblings display an exaggerated effector phenotype with heightened sensitivity to activation-induced cell deathMichael Lei Bian, Oscar Haigh, David Munster, et al.
Pediatric Diabetes|December 18, 2018
An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetesKerry Buchanan, Ahmed M Mehdi, Ian Hughes, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|May 15, 2016
Early cessation and non-response are important and possibly related problems in growth hormone therapy: An OZGROW analysisIan P Hughes, Catherine Choong, Shoshana Rath, et al.
Clinical Endocrinology|June 5, 2003
Combined pituitary hormone deficiency in Australian children: clinical and genetic correlatesKim McLennan, Yvette Jeske, Andrew Cotterill, et al.
Journal of Obesity|June 22, 2012
Diet, physical activity, and obesity in school-aged indigenous youths in northern australiaPatricia C Valery, Torukiri Ibiebele, Mark Harris, et al.
Clinical Endocrinology|August 24, 2013
Comparison of weight- vs body surface area-based growth hormone dosing for children: implications for responseIan P Hughes, Mark Harris, Andrew Cotterill, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Dual loss of rb1 and Trp53 in the adrenal medulla leads to spontaneous pheochromocytomaIan D Tonks, Arne W Mould, Wayne A Schroder, et al.
Diabetes|March 10, 2012
Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetesKatharine M Irvine, Patricia Gallego, Xiaoyu An, et al.
Pediatric Diabetes|October 10, 2020
Worldwide differences in childhood type 1 diabetes: The SWEET experienceMahira Saiyed, Dhruvi Hasnani, G Todd Alonso, et al.
Clinical Chemistry and Laboratory Medicine|June 23, 2023
Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testingKriti Joshi, Mark Harris, Andrew Cotterill, et al.
Pageof 4